ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s net foreign currency exchange gain & loss for the three months ended in Jun. 2013 was $0.0 Mil. Its net foreign currency exchange gain & loss for the trailing twelve months (TTM) ended in Jun. 2013 wa $0.0 Mil.
We are exposed to fluctuations in foreign exchange rates on the revaluation of monetary assets and liabilities denominated in currencies other than the local functional currency of the relevant subsidiary. This includes third party receivables and payables, including our Senior Notes which are denominated in Euros, as well as intercompany loans. Our subsidiaries generally receive funding via loans that are denominated in currencies other than the dollar, and any change in the relevant exchange rate will require us to recognize a transaction gain or loss on revaluation.
Onyx Pharmaceuticals, Inc. Net Foreign Currency Exchange Gain for the trailing twelve months (TTM) ended in Jun. 2013 was 0 (Sep. 2012 ) + 0 (Dec. 2012 ) + 0 (Mar. 2013 ) + 0 (Jun. 2013 ) = $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data